Epoetin theta explained

Tradename:	Biopoin, Eporatio
Atc Prefix:	None
Legal Eu:	Rx-only
Cas Number:	762263-14-9
Pubchemsubstance:	135315770
Drugbank:	DB00016
C:	815
H:	1317
N:	233
O:	241
S:	5

Epoetin theta, sold under the brand name Biopoin among others, is a copy of the human hormone erythropoietin.^{[1] [2]}

The most common side effects include shunt thrombosis (clots that can form in blood vessels of patients on dialysis, a blood clearance technique), headache, hypertension (high blood pressure), hypertensive crisis (sudden, dangerously high blood pressure), skin reactions, arthralgia (joint pain) and influenza (flu)-like illness.Epoetin theta was approved for medical use in the European Union in October 2009. It is on the World Health Organization's List of Essential Medicines.^[3]

Medical uses

Epoetin theta is indicated for the treatment of symptomatic anemia in adults.

References

attribution contains material copied from Biopoin | European Medicines Agency https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin 2021

External links

• Web site: Epoetin theta . U.S. National Library of Medicine . Drug Information Portal .

Notes and References

1. Web site: Biopoin EPAR . European Medicines Agency (EMA) . 16 December 2009 . 26 January 2021. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
2. Web site: Eporatio EPAR . European Medicines Agency (EMA) . 16 December 2009 . 26 January 2021. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
3. Book: ((World Health Organization)) . World Health Organization model list of essential medicines: 22nd list (2021) . 2021 . 10665/345533 . World Health Organization . World Health Organization . Geneva . WHO/MHP/HPS/EML/2021.02 . free .